Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Lucid Diagnostics (LUCD)

Lucid Diagnostics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:LUCD
DateTimeSourceHeadlineSymbolCompany
08/05/202421:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUCDLucid Diagnostics Inc
08/05/202421:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUCDLucid Diagnostics Inc
07/05/202412:50Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LUCDLucid Diagnostics Inc
07/05/202412:39PR Newswire (US)Lucid Diagnostics Closes Series B / B-1 Preferred Stock Offering and Appoints Healthcare Industry Veteran Dennis Matheis to Board of DirectorsNASDAQ:LUCDLucid Diagnostics Inc
02/05/202413:35PR Newswire (US)Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 13, 2024NASDAQ:LUCDLucid Diagnostics Inc
02/05/202412:49PR Newswire (US)Lucid Diagnostics Announces Peer-Reviewed Publication of Positive Data from National Cancer Institute-Sponsored, Prospective, Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer TestingNASDAQ:LUCDLucid Diagnostics Inc
29/04/202413:47PR Newswire (US)Lucid Diagnostics Partners with the Esophageal Cancer Action Network (ECAN) to Highlight Esophageal Cancer Awareness MonthNASDAQ:LUCDLucid Diagnostics Inc
08/04/202413:30PR Newswire (US)Lucid Diagnostics to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:LUCDLucid Diagnostics Inc
26/03/202423:32PR Newswire (US)PAVmed Provides Business Update and Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:LUCDLucid Diagnostics Inc
25/03/202421:30PR Newswire (US)Lucid Diagnostics Provides Business Update and Preliminary Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:LUCDLucid Diagnostics Inc
21/03/202413:30PR Newswire (US)Lucid Diagnostics Announces Positive Data from the First Prospective Clinical Validation Study of EsoGuard® Esophageal Precancer Testing in a Screening PopulationNASDAQ:LUCDLucid Diagnostics Inc
20/03/202412:30PR Newswire (US)Lucid Diagnostics Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 ConferenceNASDAQ:LUCDLucid Diagnostics Inc
12/03/202412:30PR Newswire (US)Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on March 26, 2024NASDAQ:LUCDLucid Diagnostics Inc
23/02/202421:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LUCDLucid Diagnostics Inc
16/02/202422:00PR Newswire (US)Lucid Diagnostics Provides Update Regarding World Trade Center Health ProgramNASDAQ:LUCDLucid Diagnostics Inc
15/02/202412:45PR Newswire (US)Lucid Diagnostics Chairman & CEO, Dr. Lishan Aklog, Highlights EsoCheck® Esophageal Cell Collection Device during Congressional TestimonyNASDAQ:LUCDLucid Diagnostics Inc
08/02/202412:45PR Newswire (US)Lucid Diagnostics Executes Contract to Provide EsoGuard® Esophageal Precancer Testing as a Covered Benefit for 9/11 Responders and SurvivorsNASDAQ:LUCDLucid Diagnostics Inc
06/02/202422:24Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:LUCDLucid Diagnostics Inc
06/02/202422:20Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:LUCDLucid Diagnostics Inc
30/01/202422:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LUCDLucid Diagnostics Inc
12/12/202313:30PR Newswire (US)Lucid Diagnostics Announces Peer-Reviewed Publication of Positive Results from Three Clinical Utility StudiesNASDAQ:LUCDLucid Diagnostics Inc
11/12/202314:00PR Newswire (US)PAVmed Provides Additional Details for Upcoming Stock Dividend to ShareholdersNASDAQ:LUCDLucid Diagnostics Inc
04/12/202321:20PR Newswire (US)PAVmed Announces Dividend of Lucid Diagnostics Common Stock and Reverse Stock SplitNASDAQ:LUCDLucid Diagnostics Inc
28/11/202321:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LUCDLucid Diagnostics Inc
24/11/202321:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LUCDLucid Diagnostics Inc
16/11/202314:00PR Newswire (US)Lucid Diagnostics Strengthens and Expands Market Access and Direct Contracting EffortsNASDAQ:LUCDLucid Diagnostics Inc
14/11/202322:43PR Newswire (US)PAVmed Provides Business Update and Third Quarter Financial ResultsNASDAQ:LUCDLucid Diagnostics Inc
14/11/202302:40Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LUCDLucid Diagnostics Inc
13/11/202322:40PR Newswire (US)Lucid Diagnostics Provides Business Update and Third Quarter Financial ResultsNASDAQ:LUCDLucid Diagnostics Inc
13/11/202322:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LUCDLucid Diagnostics Inc
 Showing the most relevant articles for your search:NASDAQ:LUCD